Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 2
Submit an article Journal homepage
67
Views
1
CrossRef citations to date
0
Altmetric
Original Research: Gastroenterology and Colorectal Surgery

Inpatient outcomes of inflammatory bowel disease in hospitalized patients with COVID-19: analysis of a nationally representative sample

Mohammad Aldiabata Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USAView further author information
, MD,
Saqr Alsakarnehb Department of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8776-2176View further author information
, MDORCID Icon,
Tyrell Danielc Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USAView further author information
, MD,
Muhammad Ali Buttc Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USAORCID Iconhttps://orcid.org/0000-0002-1676-8511View further author information
, MDORCID Icon,
Balaji Jagdishc Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USAView further author information
, MD,
James Rockc Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USAView further author information
, MD,
Aarushi Sudand Department of Medicine, Jacobi Medical Center, Franklin Square, New York, USAView further author information
, MD,
Majd Al-Ahmade Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USAView further author information
, MD,
Ahmad Jabrif Heart and Vascular Center, Metro Health Medical Center, Cleveland, Ohio, USAView further author information
, MD,
Yassine Kilanig Lincoln Medical Center/Weil Cornell Medicine, Bronx, New York, USAView further author information
, MD,
Tarek Odaha Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USAView further author information
, MD,
Laith Alhuneafatc Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, USAORCID Iconhttps://orcid.org/0000-0003-4763-5751View further author information
, MDORCID Icon,
Mir Zulqarnainh Department of Gastroenterology and Hepatology, University of Missouri-Kansas City, Kansas City, Missouri, USAView further author information
, MD,
Jana G. Hashashi Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USAView further author information
, MD, MSc &
Hassan Ghozh Department of Gastroenterology and Hepatology, University of Missouri-Kansas City, Kansas City, Missouri, USAView further author information
, MD show all
Pages 239-247 | Received 12 Oct 2023, Accepted 23 Dec 2023, Published online: 26 Jan 2024

  • Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12(Suppl 1):S3–8.
  • Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–99. doi:10.3748/wjg.v20.i1.91.
  • Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472. doi:10.1111/jth.14848.
  • Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost. 2020;46(7):763–771. doi:10.1055/s-0040-1715456.
  • Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365–388. doi:10.1080/10408363.2020.1783198.
  • COVID-19 Map – Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed March 12, 2023.
  • Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768.
  • Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51(9):843–851. doi:10.1111/apt.15731.
  • Sharma E, Meade S, D'Errico F, et al. The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre. GastroHep. 2020;2(6):318–326. doi:10.1002/ygh2.433.
  • Rubin DT, Abreu MT, Rai V, et al. Management of patients with Crohn’s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting. Gastroenterology. 2020;159(1):6–13.e6. doi:10.1053/j.gastro.2020.04.002.
  • Tripathi K, Godoy Brewer G, Thu Nguyen M, et al. COVID-19 and outcomes in patients with inflammatory bowel disease: systematic review and meta-analysis. Inflamm Bowel Dis. 2022;28(8):1265–1279. doi:10.1093/ibd/izab236.
  • Healthcare Cost and Utilization Project—HCUP. A federal-state-industry partnership in health data. 2019.
  • HCUP-US NIS Overview. https://www.hcup-us.ahrq.gov/nisoverview.jsp#about. Accessed January 2, 2023.
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X.
  • Aniwan S, Harmsen WS, Tremaine WJ, Loftus EV. Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010. Therap Adv Gastroenterol. 2019;12:1756284819827692. doi:10.1177/1756284819827692.
  • Wang YR, Loftus EV, Cangemi JR, Picco MF. Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013;88(1):20–25. doi:10.1159/000350759.
  • Greuter T, Manser C, Pittet V, Vavricka SR, Biedermann L, on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Gender differences in inflammatory bowel disease. Digestion. 2020;101(Suppl1):98–104. doi:10.1159/000504701.
  • Jess T, Jensen BW, Andersson M, Villumsen M, Allin KH. Inflammatory bowel diseases increase risk of type 2 diabetes in a nationwide cohort study. Clin Gastroenterol Hepatol. 2020;18(4):881–888.e1. doi:10.1016/j.cgh.2019.07.052.
  • Sang MM, Sun ZL, Wu TZ. Inflammatory bowel disease and diabetes: Is there a link between them? World J Diabetes. 2022;13(2):126–128. doi:10.4239/wjd.v13.i2.126.
  • Arora A, Behl T, Sehgal A, et al. Unravelling the involvement of gut microbiota in type 2 diabetes mellitus. Life Sci. 2021;273:119311. doi:10.1016/j.lfs.2021.119311.
  • Holst JJ, Gribble F, Horowitz M, Rayner CK. Roles of the gut in glucose homeostasis. Diabetes Care. 2016;39(6):884–892. doi:10.2337/dc16-0351.
  • Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2021;33(3):151–157. doi:10.1016/j.artere.2021.04.004.
  • Lv F, Gao X, Huang AH, et al. Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States. EClinicalMedicine. 2022;54:101671. doi:10.1016/j.eclinm.2022.101671.
  • Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL. Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. Obesity (Silver Spring). 2020;28(9):1595–1599. doi:10.1002/oby.22913.
  • Biedermann L, Fournier N, Misselwitz B, et al. High rates of smoking especially in female Crohn’s disease patients and low use of supportive measures to achieve smoking cessation—data from the Swiss IBD cohort study. J Crohns Colitis. 2015;9(10):819–829. doi:10.1093/ecco-jcc/jjv113.
  • Gaspar R, Macedo G, Branco CC. Liver manifestations and complications in inflammatory bowel disease: a review. World J Hepatol. 2021;13(12):1956–1967.
  • Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J. 2020;56(2):56.
  • Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147.
  • Bezzio C, Saibeni S, Variola A, et al. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69(7):1213–1217. doi:10.1136/gutjnl-2020-321411.
  • Parekh R, Zhang X, Ungaro RC, et al. Presence of comorbidities associated with severe coronavirus infection in patients with inflammatory bowel disease. Dig Dis Sci. 2022;67(4):1271–1277. doi:10.1007/s10620-021-07104-0.
  • Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52(2):276–283. doi:10.1111/apt.15804.
  • Hadi Y, Dulai PS, Kupec J, et al. Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis. Aliment Pharmacol Ther. 2022;55(2):191–200. doi:10.1111/apt.16730.
  • Ludvigsson JF, Axelrad J, Halfvarson J, et al. Inflammatory bowel disease and risk of severe COVID-19: a nationwide population-based cohort study in Sweden. United European Gastroenterol J. 2021;9(2):177–192. doi:10.1002/ueg2.12049.
  • Lee MH, Li HJ, Wasuwanich P, et al. COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: an updated systematic review and meta-analysis. Rev Med Virol. 2023;33(2):e2414.
  • Nowak JK, Lindstrøm JC, Kalla R, Ricanek P, Halfvarson J, Satsangi J. Age, inflammation, and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease. Gastroenterology. 2020;159(3):1151–1154.e2. doi:10.1053/j.gastro.2020.05.030.
  • Franco-Moreno A, Herrera-Morueco M, Mestre-Gómez B, et al. Incidence of deep venous thrombosis in patients with COVID-19 and pulmonary embolism: compression ultrasound COVID study. J Ultrasound Med. 2021;40(7):1411–1416. doi:10.1002/jum.15524.
  • Birocchi S, Manzoni M, Podda GM, Casazza G, Cattaneo M. High rates of pulmonary artery occlusions in COVID‐19. A meta‐analysis. Eur J Clin Invest. 2021;51(1):e13433. doi:10.1111/eci.13433.
  • Fauvel C, Weizman O, Trimaille A, et al. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J. 2020;41(32):3058–3068. doi:10.1093/eurheartj/ehaa500.
  • Chung WS, Lin CL, Hsu WH, Kao CH. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study. Thromb Res. 2015;135(3):492–496. doi:10.1016/j.thromres.2014.12.025.
  • Santoliquido A, Porfidia A, Nesci A, et al. Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis. J Thromb Haemost. 2020;18(9):2358–2363. doi:10.1111/jth.14992.
  • Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60(7):937–943. doi:10.1136/gut.2010.228585.
  • Setyawan J, Mu F, Zichlin ML, et al. Risk of thromboembolic events and associated healthcare costs in patients with inflammatory bowel disease. Adv Ther. 2022;39(1):738–753. doi:10.1007/s12325-021-01973-7.
  • Elshazli RM, Kline A, Elgaml A, et al. Gastroenterology manifestations and COVID-19 outcomes: a meta-analysis of 25,252 cohorts among the first and second waves. J Med Virol. 2021;93(5):2740–2768. doi:10.1002/jmv.26836.
  • Martin TA, Wan DW, Hajifathalian K, et al. Gastrointestinal bleeding in patients with coronavirus disease 2019: a matched case-control study. Am J Gastroenterol. 2020;115(10):1609–1616. doi:10.14309/ajg.0000000000000805.
  • Horby P, Lim WS, Emberson JR, et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704. doi:10.1056/NEJMoa2021436.
  • Iqbal U, Anwar H, Siddiqui HU, et al. Acute gastrointestinal bleeding in COVID-19 patients: a systematic review and meta-analysis. Clin Endosc. 2021;54(4):534–541. doi:10.5946/ce.2021.071.
  • Kim KJ, Han BJ, Yang SK, et al. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn’s disease. Dig Liver Dis. 2012;44(9):723–728. doi:10.1016/j.dld.2012.03.010.
  • Głowacka M, Lipka S, Młynarska E, Franczyk B, Rysz J. Acute kidney injury in COVID-19. Int J Mol Sci. 2021;22(15).
  • Neugarten J, Bellin E, Yunes M, et al. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol. 2020;31(9):2145–2157. doi:10.1681/ASN.2020040509.
  • Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218. doi:10.1016/j.kint.2020.05.006.
  • Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi:10.1016/j.kint.2020.03.005.
  • Vajravelu RK, Copelovitch L, Osterman MT, et al. Inflammatory bowel diseases are associated with an increased risk for chronic kidney disease, which decreases with age. Clin Gastroenterol Hepatol. 2020;18(10):2262–2268. doi:10.1016/j.cgh.2019.10.043.
  • Achit H, Peyrin-Biroulet L, Ayav C, Guillemin F, Frimat L. Lack of monitoring is associated with risk of acute kidney events among patients with inflammatory bowel disease. J Clin Med. 2022;11(11).
  • van Hoeve K, Hoffman I. Renal manifestations in inflammatory bowel disease: a systematic review. J Gastroenterol. 2022;57(9):619–629.
  • Shah VA, Nalleballe K, Zaghlouleh ME, Onteddu S. Acute encephalopathy is associated with worse outcomes in COVID-19 patients. Brain Behav Immun Health. 2020;8:100136. doi:10.1016/j.bbih.2020.100136.
  • Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):E1060–e1070. doi:10.1212/WNL.0000000000009937.
  • Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45(3 Pt 1):416–421.
  • Oudman E, Wijnia JW, Oey MJ, van Dam M, Postma A. Wernicke’s encephalopathy in Crohn’s disease and ulcerative colitis. Nutrition. 2021;86:111182.
  • Kaafarani HMA, El Moheb M, Hwabejire JO, et al. Gastrointestinal complications in critically ill patients with COVID-19. Ann Surg. 2020;272(2):e61–2–e62. doi:10.1097/SLA.0000000000004004.
  • El Moheb M, Naar L, Christensen MA, et al. Gastrointestinal complications in critically ill patients with and without COVID-19. JAMA. 2020;324(18):1899–1901. doi:10.1001/jama.2020.19400.
  • Dai X, Ge X, Yang J, et al. Increased incidence of prolonged ileus after colectomy for inflammatory bowel diseases under ERAS protocol: a cohort analysis. J Surg Res. 2017;212:86–93. doi:10.1016/j.jss.2016.12.031.
  • Malhi G, Minhas G, Chambers J, Mikail M, Khanna R, Wilson A. Increased hospitalization for IBD patients seen in the ER during the COVID-19 pandemic. J Can Assoc Gastroenterol. 2022;5(6):271–275. doi:10.1093/jcag/gwac020.
  • Williams C, Panaccione R, Ghosh S, Rioux K. Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therap Adv Gastroenterol. 2011;4(4):237–248. doi:10.1177/1756283X11405250.
  • Creemers RH, Ardabili AR, Jonkers DM, et al. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting. PLoS One. 2021;16(10):e0258271. doi:10.1371/journal.pone.0258271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.